Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
What Are The Forecasted Market Size Estimates For The Degenerative Disc Disease Treatment Market Between 2025 And 2029?
The market encompassing treatments for degenerative disc disease has witnessed substantial expansion lately, projecting an increase from its 2024 valuation of $27.07 billion to $28.79 billion by 2025, reflecting a consistent compound annual growth rate of 6.3%. This upward trajectory observed over the past period is largely attributable to several key factors, including the demographic shift towards an older population, increasingly sedentary habits, significant progress in medical technologies, heightened public understanding of the condition, escalating prevalence of obesity, a rise in sports-related injuries, and broader availability of healthcare services.
Anticipated for the coming years is substantial expansion within the market for degenerative disc disease treatments, projected to reach a valuation of $37.41 billion by 2029, reflecting a compounded annual growth rate (CAGR) of 6.8%. This upward trajectory throughout the projection timeframe stems from several factors, notably increasing outlays on healthcare, escalating need for less invasive surgical options, improved patient awareness, broader clinical investigations, and a higher prevalence of spinal ailments worldwide. Key developments defining this period involve incorporating artificial intelligence and machine learning capabilities, progress in regenerative therapies, evolution of minimally invasive surgical techniques, adoption of wearable devices, utilization of 3D printing for bespoke implants, expansion of telehealth services for remote patient interactions, and a shift toward individualized treatment plans.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18784&type=smp
What Are The Emerging Market Drivers Creating New Opportunities In The Degenerative Disc Disease Treatment Industry?
The increasing incidence of sports-related injuries is anticipated to serve as a key catalyst for the expansion of the market focused on treating degenerative disc disease. These physical damages or traumas, sustained by those participating in sports or rigorous physical endeavors, frequently stem from abrupt force, repetitive stress, or flawed execution of movements. Factors like elevated involvement levels, more demanding practice schedules, and a heightened focus on achieving competitive superiority frequently explain the upward trend in sports injuries. Treatments for degenerative disc disease find application here to address persistent discomfort in the spine and recover lost physical capabilities when disc deterioration negatively affects an athlete’s movement and competitive ability. To illustrate this impact, data presented by the Howden Group Holdings Ltd, an insurance intermediary based in the UK, indicated that injuries recorded in October 2022 caused players to miss an average of 11.35 days prior to competitions; this recovery period escalated to 19.41 days by January 2023. Consequently, the escalating volume of injuries sustained in sports activities is what fuels the advancement of the degenerative disc disease treatment sector.
What Are The Major Segment Types Covered In The Degenerative Disc Disease Treatment Market?
The degenerative disc disease treatmentmarket covered in this report is segmented –
1) By Type: Conventional Drugs, Novel Therapies
2) By Route Of Administration: Oral, Injectable
3) By End User: Hospitals, Ambulatory Surgical Centers, Orthopedic Center
Subsegments:
1) By Conventional Drugs: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Opioids, Muscle Relaxants, Corticosteroids, Antidepressants
2) By Novel Therapies: Gene Therapy, Stem Cell Therapy, Platelet-Rich Plasma (PRP) Therapy, Biologic Agents, Regenerative Medicine, Cell-Based Therapies, Growth Factor Therapies
Which Key Trends Are Expected To Influence The Degenerative Disc Disease Treatment Market In The Coming Years?
Leading corporations actively participating in the degenerative disc disease treatment arena are concentrating their efforts on pioneering new modalities, specifically injectable disc cell therapy (IDCT), with the goal of enhancing clinical results through the restoration of disc volume, the mitigation of discomfort experienced in the lower back, and a subsequent decrease in reliance on pharmaceutical analgesics. This restorative intervention, namely IDCT, is specifically designed to address lumbar degenerative disc disease that manifests with symptoms. As an illustration, during February of 2023, the US biopharmaceutical entity, DiscGenics Inc., was granted regenerative medicine advanced therapy status by the FDA for its IDCT product, which is intended for the management of symptomatic lumbar degenerative disc disease. This groundbreaking treatment employs a viable population of progenitor cells sourced from intervertebral disc tissue donated by adults. The capacity of IDCT exists to augment the size of the disc, provide relief from chronic low back pain, and diminish the therapeutic necessity for pain-reducing drugs among individuals suffering from the condition.
Which Major Firms Are Strengthening Their Position In The Degenerative Disc Disease Treatment Industry?
Major companies operating in the degenerative disc disease treatment market are Pfizer Inc., Johnson And Johnson, Sanofi S.A., AstraZeneca Plc, Novartis AG, GlaxoSmithKline PLC, Medtronic plc, Amgen Inc., Baxter International Inc., B. Braun SE, Zimmer Biomet Holdings Inc., Arthrex Inc., Ferring B.V., Biocon Limited, Integra LifeSciences Holdings Corporation, NuVasive Inc., Globus Medical Inc., Orthofix Medical Inc., RTI Surgical Holdings Inc., LifeNet Health
Download The Full Report For Exclusive Market Findings:
Which Global Regions Are Influencing The Competitive Landscape Of The Degenerative Disc Disease Treatment Market?
North America was the largest region in the degenerative disc disease treatment market in 2024. The regions covered in the degenerative disc disease treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Degenerative Disc Disease Treatment Market Report:
https://www.thebusinessresearchcompany.com/customise?id=18784&type=smp
Browse Through More Reports Similar to the Global Degenerative Disc Disease Treatment Market 2025, By The Business Research Company
Neurodegenerative Disorder Therapeutic Global Market Report 2025
Inflammatory Bowel Disease Treatment Global Market Report 2025
Chronic Disease Management Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/chronic-disease-management-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model